Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Montana.
Press releases published on September 24, 2025
Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital
Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital Clarification in Response to Unfounded Accusations NANTES, France – September 24, 2025, 8:00 a.m. CET – OSE Immunotherapeutics SA (ISIN: …
Correction d’une erreur matérielle relative au nombre total de droits de vote et d’actions composant le capital
Correction d’une erreur matérielle relative au nombre total de droits de vote et d’actions composant le capital Mise au Point Face aux Accusations Infondées Nantes, le 24 septembre 2025 à 8 h 00 CET –OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : …
Aesthetics Ave Elevates Non-Surgical Cosmetic Treatments in Midland, TX
Offering Facial Fillers, Wrinkle Reduction, Non-Surgical Facelifts, and Morpheus 8 Skin Treatments for Natural, Youthful Results MIDLAND, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Aesthetics Ave, a premier destination for advanced cosmetic and aesthetic …
Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health
The studies established the lead asset to be well tolerated in healthy volunteers at all doses with a good safety profile SYT-510 demonstrated penetration in the central nervous system and a pharmacodynamic effect on the brain BASEL, Switzerland, Sept. 24, …
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund will remain focused on Sanofi's key areas of immunology, rare diseases, neurology, and vaccines, backing earlier-stage …
Communiqué de presse : Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique
Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique Le fonds restera axé sur les domaines clés de Sanofi que sont l’ …
Dimora PHMB Skin and Wound Cleanser - Gentle for Kids, Trusted by Parents
SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Dimora Medical is proud to introduce its newest innovation, the Dimora PHMB Skin and Wound Cleanser. Designed with children’s needs in mind, this product offers a gentle, odorless alternative to traditional …
Press release: Availability of the Q3 2025 Aide mémoire
Availability of the Q3 2025 Aide mémoire Paris, France – September 24, 2025. Sanofi announced today that its Q3 2025 Aide mémoire is available on the "Investors" page of the company's website: Third quarter 2025 (sanofi.com) As for each quarter, Sanofi …
Communiqué de presse : Mise en ligne du document "Q3 2025 Aide mémoire"
Mise en ligne du document «Q3 2025 Aide mémoire » Paris, France, le 24 septembre 2025. Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q3 2025 Aide mémoire ». Résultats du troisième …
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics”, “Monopar”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical …
Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced …
Elevé Cosmetic Surgery Officially Opens in Coral Gables, Accepting a Limited Number of Patients Seeking a Boutique Surgical Experience
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Elevé Cosmetic Surgery, a new boutique practice in Coral Gables, today announced that it is officially open and accepting a limited number of new patients for facial and body procedures. Led by board-certified …